Abstract
Introduction: Pleural biopsies are of great diagnostic utility for the study of pleural pathology. Abrams needles continue to be widely used. However, a higher profitability of cutting needles is described, due to technical differences in sample collection. The objective of our study is to compare the profitability of pleural tissue collection by cutting needles versus ecologically assisted Abrams needles. Material and Methods: We conducted a retrospective, observational study comparing the cost-effectiveness of pleural tissue collection using sharp needles versus traditional Abrams needles, all assisted by ultrasound. Pleural biopsies performed during 2023 by a single operator trained in both techniques were selected. Sixty-nine patients with exudative pleural effusion who required pleural biopsies as part of the diagnostic procedure were included. 19 were sharp needle biopsies and 50 were Abrams needle biopsies. A descriptive study of the results was conducted. Results: Pleural needle biopsies obtained pleural tissue in 79% of cases and Abrams needle biopsies obtained 68%. The most frequent diagnoses obtained with the sharp needle were: neoplasia (20%), TB (26.6%) and nonspecific chronic inflammatory disease (53.3%). The most frequent diagnoses obtained with the Abrams needle were: neoplasia (55.8%), TB (17.6%) and nonspecific chronic inflammatory disease (26.4%). Chi-square test (P = 0.38) showed no statistically significant difference. Conclusions: There was no significant difference between the two techniques, thus presenting a valid alternative to ultrasound-assisted closed pleural biopsies without affecting our diagnostic yield.